Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
193
datasets available to search
ShareScore release 0.9.0
Dataset results
193 results for “CD20”
GVHD Prophylaxis by Addition of CD20 Monoclonal Antibody to the Conditioning Regimen in SAA With Treatment of Allo-HSCT
ClinicalTrials.gov study NCT05510505. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess the Pharmacokinetics and Safety of Recombinant Human Murine Chimeric Anti CD20 Monoclonal Antibody Injection (IBI301) Compared to Rituximab Injection in CD20 Positive B Cell Lymphoma
ClinicalTrials.gov study NCT02945215. IPD Sharing: NO. Countries: 1. Publications: 0.
GP2013 in Japanese Patients With CD20 Positive Low Tumor Burden Indolent B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01933516. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Clinical Study of Zanubrutinib Combined With Four Cycles of CD20 Monoclonal Antibody and Reduced-Dose Bendamustine in the Treatment of Untreated Waldenström Macroglobulinemia
ClinicalTrials.gov study NCT07259122. IPD Sharing: NO. Countries: 1. Publications: 0.
B001 in Patients With CD20 Positive B-cell Non Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03332121. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab Maintenance Therapy in Aggressive CD20 (Cluster of Differentiation Antigen 20) Positive Lymphoma and Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01933711. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rehabilitative Protocols in Progressive Multiple Sclerosis Treated with Anti CD20 Monoclonal Antibodies
ClinicalTrials.gov study NCT06894940. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
ClinicalTrials.gov study NCT06542250. IPD Sharing: YES. Countries: 10. Publications: 0.
A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06464185. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicular Lymphoma
ClinicalTrials.gov study NCT04404088. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL.
ClinicalTrials.gov study NCT05395533. IPD Sharing: NO. Countries: 1. Publications: 0.
Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody
ClinicalTrials.gov study NCT06688331. IPD Sharing: NO. Countries: 1. Publications: 0.
COVID-19 Infection in Patients Receiving Anti-CD20 Therapy
ClinicalTrials.gov study NCT04884477. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT03458260. IPD Sharing: NO. Countries: 2. Publications: 0.
Prednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic Anemia
ClinicalTrials.gov study NCT01134432. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL
ClinicalTrials.gov study NCT04491721. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Study of TRS005 in Patients With CD20-positive R/R DLBCL.
ClinicalTrials.gov study NCT06886139. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Research of CD20-Targeted CAR-T in B Cell Malignancies
ClinicalTrials.gov study NCT02710149. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies
ClinicalTrials.gov study NCT05653271. IPD Sharing: NO. Countries: 3. Publications: 0.
A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
ClinicalTrials.gov study NCT05668403. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.